Shared biology of GVHD and GVT effects: Potential methods of separation
- 31 March 2006
- journal article
- research article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 57 (3), 225-244
- https://doi.org/10.1016/j.critrevonc.2005.07.001
Abstract
No abstract availableKeywords
This publication has 283 references indexed in Scilit:
- Depsipeptide (FR901228) Enhances the Cytotoxic Activity of TRAIL by Redistributing TRAIL Receptor to Membrane Lipid RaftsMolecular Therapy, 2005
- A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis ProteinsClinical Cancer Research, 2005
- Palifermin for Oral Mucositis after Intensive Therapy for Hematologic CancersNew England Journal of Medicine, 2004
- Cytotoxic T Lymphocyte-Associated Antigen 4 Blockade in Patients with Metastatic MelanomaJournal of Immunotherapy, 2004
- Putting the Rap on AktJournal of Clinical Oncology, 2004
- The Mortimer M. Bortin lecture: to destroy by the reaction of immunity: the search for separation of graft-versus-leukemia and graft-versus-hostTransplantation and Cellular Therapy, 2004
- CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effectsBlood, 2003
- Safety and antitumor activity of recombinant soluble Apo2 ligandJCI Insight, 1999
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979